FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Personalized Breast Cancer Treatment; Insights Into HPV in Men; Exercise and Cancer

2.

In heavily pretreated DLBCL, Triplet Scores a Survival Victory.

3.

Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds

4.

Efanesoctocog Alfa Prevented Bleeding in Kids With Severe Hemophilia A

5.

Eight Doctors Killed in Brazil's Horrifying Plane Crash


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot